• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢型谷氨酸受体2(mGlu2)的变构增强剂。第3部分:含茚满酮的mGlu2受体增强剂的鉴定及生物学活性

Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators.

作者信息

Pinkerton Anthony B, Cube Rowena V, Hutchinson John H, James Joyce K, Gardner Michael F, Rowe Blake A, Schaffhauser Hervé, Rodriguez Dana E, Campbell Una C, Daggett Lorrie P, Vernier Jean-Michel

机构信息

Merck Research Laboratories, MRLSDB2, 3535 General Atomics Court, San Diego, CA 92121, USA.

出版信息

Bioorg Med Chem Lett. 2005 Mar 15;15(6):1565-71. doi: 10.1016/j.bmcl.2005.01.077.

DOI:10.1016/j.bmcl.2005.01.077
PMID:15745798
Abstract

We have identified and synthesized a series of phenyl-tetrazolyl and 4-thiopyridyl indanones as allosteric potentiators of the metabotropic glutamate receptor 2. Structure activity relationship studies directed toward improving the potency and level of potentiation, as well as PK properties, led to the discovery of 28 (EC50=186 nM), which displayed activity in a rodent model for schizophrenia.

摘要

我们已经鉴定并合成了一系列苯基四唑基和4-硫代吡啶基茚满酮,作为代谢型谷氨酸受体2的变构增强剂。旨在提高效力、增强水平以及药代动力学性质的构效关系研究,促成了化合物28(EC50 = 186 nM)的发现,该化合物在啮齿动物精神分裂症模型中显示出活性。

相似文献

1
Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiators.代谢型谷氨酸受体2(mGlu2)的变构增强剂。第3部分:含茚满酮的mGlu2受体增强剂的鉴定及生物学活性
Bioorg Med Chem Lett. 2005 Mar 15;15(6):1565-71. doi: 10.1016/j.bmcl.2005.01.077.
2
Biphenyl-indanones: allosteric potentiators of the metabotropic glutamate subtype 2 receptor.联苯茚满二酮:亲代谢型谷氨酸受体2亚型的变构增强剂。
Bioorg Med Chem Lett. 2005 Oct 1;15(19):4354-8. doi: 10.1016/j.bmcl.2005.06.062.
3
Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 2: 4-thiopyridyl acetophenones as non-tetrazole containing mGlu2 receptor potentiators.代谢型谷氨酸受体2(mGlu2)的变构增强剂。第2部分:4-硫代吡啶基苯乙酮作为不含四氮唑的mGlu2受体增强剂。
Bioorg Med Chem Lett. 2004 Dec 6;14(23):5867-72. doi: 10.1016/j.bmcl.2004.09.028.
4
Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 1: Identification and synthesis of phenyl-tetrazolyl acetophenones.代谢型谷氨酸受体2(mGlu2)的变构增强剂。第1部分:苯基四唑基苯乙酮的鉴定与合成。
Bioorg Med Chem Lett. 2004 Nov 1;14(21):5329-32. doi: 10.1016/j.bmcl.2004.08.020.
5
Phenyl-tetrazolyl acetophenones: discovery of positive allosteric potentiatiors for the metabotropic glutamate 2 receptor.苯基 - 四唑基苯乙酮:代谢型谷氨酸2受体正向变构增强剂的发现
J Med Chem. 2004 Aug 26;47(18):4595-9. doi: 10.1021/jm040088h.
6
Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia.苯并唑类作为代谢型谷氨酸受体2(mGluR2)的变构增强剂:在精神分裂症动物模型中的疗效
Bioorg Med Chem Lett. 2005 Sep 15;15(18):4068-72. doi: 10.1016/j.bmcl.2005.06.017.
7
Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.代谢型谷氨酸受体的变构调节剂:从mGlu1、mGlu2和mGlu5增强剂及拮抗剂中获得的经验教训。
Biochem Soc Trans. 2004 Nov;32(Pt 5):881-7. doi: 10.1042/BST0320881.
8
Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine.代谢型谷氨酸受体2变构增强剂的发现:N-(4-(2-甲氧基苯氧基)苯基)-N-(2,2,2-三氟乙基磺酰基)吡啶-3-基甲胺的合成及亚型选择性
J Med Chem. 2003 Jul 17;46(15):3189-92. doi: 10.1021/jm034015u.
9
Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.联苯茚满二酮A,一种亲代谢型谷氨酸受体亚型2的正变构调节剂,在小鼠中具有抗精神病样和抗焦虑样作用。
J Pharmacol Exp Ther. 2006 Jul;318(1):173-85. doi: 10.1124/jpet.106.102046. Epub 2006 Apr 11.
10
SAR study of a subtype selective allosteric potentiator of metabotropic glutamate 2 receptor, N-(4-phenoxyphenyl)-N-(3-pyridinylmethyl)ethanesulfonamide.代谢型谷氨酸2受体亚型选择性变构增强剂N-(4-苯氧基苯基)-N-(3-吡啶基甲基)乙磺酰胺的构效关系研究
Bioorg Med Chem Lett. 2004 Jun 21;14(12):3099-102. doi: 10.1016/j.bmcl.2004.04.017.

引用本文的文献

1
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs.作为新型抗精神病药物靶点的II组代谢型谷氨酸受体
Front Pharmacol. 2016 May 20;7:130. doi: 10.3389/fphar.2016.00130. eCollection 2016.
2
Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment.用于精神分裂症治疗的代谢型谷氨酸2受体正向变构调节剂。
Trends Neurosci. 2015 Aug;38(8):506-16. doi: 10.1016/j.tins.2015.06.002. Epub 2015 Jul 4.
3
Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence.
全身性活性代谢型谷氨酸2型和3型(mGlu2/3)受体正向变构调节剂(PAMs)的设计与合成:在可卡因依赖大鼠模型中的药理学特性及评估
J Med Chem. 2014 May 22;57(10):4154-72. doi: 10.1021/jm5000563. Epub 2014 May 9.
4
Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signaling.精神分裂症治疗的新兴方法:谷氨酸能信号传导的调节
Discov Med. 2012 Nov;14(78):335-43.
5
Therapeutic potential of metabotropic glutamate receptor modulators.代谢型谷氨酸受体调节剂的治疗潜力。
Curr Neuropharmacol. 2012 Mar;10(1):12-48. doi: 10.2174/157015912799362805.
6
Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.近期 II 组代谢型谷氨酸受体变构调节剂的合成与表征研究进展。
ACS Chem Neurosci. 2011 Aug 17;2(8):382-93. doi: 10.1021/cn200008d. Epub 2011 Apr 12.
7
Allosteric modulation of metabotropic glutamate receptors.代谢型谷氨酸受体的变构调节
Adv Pharmacol. 2011;62:37-77. doi: 10.1016/B978-0-12-385952-5.00010-5.
8
Metabotropic glutamate receptors as therapeutic targets for schizophrenia.代谢型谷氨酸受体作为精神分裂症的治疗靶点。
Neuropharmacology. 2012 Mar;62(3):1461-72. doi: 10.1016/j.neuropharm.2011.05.005. Epub 2011 May 19.
9
Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats.设计并合成一种可口服的代谢型谷氨酸受体 2 型(mGluR2)别构调节剂(PAM),该调节剂可减少大鼠的可卡因自我给药。
J Med Chem. 2011 Jan 13;54(1):342-53. doi: 10.1021/jm1012165. Epub 2010 Dec 14.
10
Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.变构调节代谢型谷氨酸受体:结构见解与治疗潜力。
Neuropharmacology. 2011 Jan;60(1):66-81. doi: 10.1016/j.neuropharm.2010.07.007. Epub 2010 Jul 14.